Arthritis Research & Therapy · 2010 · 121 citations · 55 references
Life SciencesImmunologyPathobiologyAutoimmunityImmunoregulationInflammationAutoimmune DiseasesAutoimmune InflammationCytokine BiologyImmune-mediated DiseaseInflammatory SignalingSystemic Lupus ErythematosusAnimal Disease ModelsImmunoregulatory SignalingInhibition Of Interferon ResponsesInterferon-mediated PathologyMultiple Sclerosis TherapyType I Interferon Pathways
Type I interferons are pleiotropic cytokines with antiviral, antitumor and immunoregulatory functions. An aspect of their complex biology is the paradox that, depending on context, type I interferons can be anti-inflammatory and tissue protective or can be proinflammatory and promote autoimmunity. Along these lines, the activation of type I interferon pathways is effective in suppressing disease activity in patients with multiple sclerosis and in animal models of arthritis and colitis, while there is an expectation that blockade of the same pathways will be beneficial in the treatment of patients with systemic lupus erythematosus.
55
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Akinori Takaoka, Zhichao Wang, Myoung Kwon Choi et al. · Nature · 2007 · 1.7K citations
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Patrick Blanco, A. Karolina Palucka, Michelle A. Gill et al. · Science · 2001 · 1.3K citations
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
Jonathan C. Kagan, Tian Su, Tiffany Horng et al. · Nature Immunology · 2008 · 1.2K citations